The United Kingdom has secured a deal for initial delivery of 5 million doses of a brand new vaccine developed by the US biotech firm, Moderna.
The vaccine could be delivered from spring 2021 if it’s approved by the regulator. The health secretary for England Matt Hancock warned that the safety data was limited and the firm’s production facilities were not yet fully developed.
Moderna says the trials so far show the vaccine is almost 95% effective. It’s been tested on a range of people. And it can be stored at normal refrigerated temperatures making it much easier to distribute than the Pfizer vaccine announced recently.
Huw Edwards presents BBC News at Ten reporting by medical editor Fergus Walsh.